Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

Phenotypic and functional characterisation of ovine mesenchymal stem cells: application to a cartilage defect model.

Mrugala D, Bony C, Neves N, Caillot L, Fabre S, Moukoko D, Jorgensen C, Noël D.

Ann Rheum Dis. 2008 Mar;67(3):288-95. Epub 2007 Jul 20.

PMID:
17644536
2.

Characterisation and developmental potential of ovine bone marrow derived mesenchymal stem cells.

McCarty RC, Gronthos S, Zannettino AC, Foster BK, Xian CJ.

J Cell Physiol. 2009 May;219(2):324-33. doi: 10.1002/jcp.21670.

PMID:
19115243
3.

Repair of full-thickness articular cartilage defects by cultured mesenchymal stem cells transfected with the transforming growth factor beta1 gene.

Guo X, Zheng Q, Yang S, Shao Z, Yuan Q, Pan Z, Tang S, Liu K, Quan D.

Biomed Mater. 2006 Dec;1(4):206-15. doi: 10.1088/1748-6041/1/4/006. Epub 2006 Sep 22.

PMID:
18458408
4.

[Three dimensional induction of autologous mesenchymal stem cell and the effects on depressing long-term degeneration of tissue-engineering cartilage].

Lü CW, Hu YY, Bai JP, Liu J, Meng GL, Lü R.

Zhonghua Wai Ke Za Zhi. 2007 Dec 15;45(24):1717-21. Chinese.

PMID:
18476534
5.

Multipotent mesenchymal stromal cells in articular diseases.

Jorgensen C, Djouad F, Bouffi C, Mrugala D, Noël D.

Best Pract Res Clin Rheumatol. 2008 Apr;22(2):269-84. doi: 10.1016/j.berh.2008.01.005. Review.

PMID:
18455684
6.

Ovine bone- and marrow-derived progenitor cells and their potential for scaffold-based bone tissue engineering applications in vitro and in vivo.

Reichert JC, Woodruff MA, Friis T, Quent VM, Gronthos S, Duda GN, Schütz MA, Hutmacher DW.

J Tissue Eng Regen Med. 2010 Oct;4(7):565-76. doi: 10.1002/term.276.

PMID:
20568083
7.

Ovine bone marrow mesenchymal stem cells: isolation and characterization of the cells and their osteogenic differentiation potential on embroidered and surface-modified polycaprolactone-co-lactide scaffolds.

Rentsch C, Hess R, Rentsch B, Hofmann A, Manthey S, Scharnweber D, Biewener A, Zwipp H.

In Vitro Cell Dev Biol Anim. 2010 Jul;46(7):624-34. doi: 10.1007/s11626-010-9316-0. Epub 2010 May 20.

PMID:
20490706
8.

Evaluation of posterolateral spinal fusion using mesenchymal stem cells: differences with or without osteogenic differentiation.

Nakajima T, Iizuka H, Tsutsumi S, Kayakabe M, Takagishi K.

Spine (Phila Pa 1976). 2007 Oct 15;32(22):2432-6.

PMID:
18090081
9.

Development of a new method to harvest chondroprogenitor cells from underneath cartilage defects in the knees.

Elvenes J, Knutsen G, Johansen O, Moe BT, Martinez I.

J Orthop Sci. 2009 Jul;14(4):410-7. doi: 10.1007/s00776-009-1349-4. Epub 2009 Aug 7.

PMID:
19662475
10.

Low oxygen expansion improves subsequent chondrogenesis of ovine bone-marrow-derived mesenchymal stem cells in collagen type I hydrogel.

Zscharnack M, Poesel C, Galle J, Bader A.

Cells Tissues Organs. 2009;190(2):81-93. doi: 10.1159/000178024. Epub 2008 Nov 25.

PMID:
19033681
11.
12.

The effect of a chitosan-gelatin matrix and dexamethasone on the behavior of rabbit mesenchymal stem cells.

Medrado GC, Machado CB, Valerio P, Sanches MD, Goes AM.

Biomed Mater. 2006 Sep;1(3):155-61. doi: 10.1088/1748-6041/1/3/010. Epub 2006 Aug 9.

PMID:
18458397
13.

[The primary study on rabbit bone marrow mesenchymal stem cells in constructing tissue-engineered cartilage].

Shan YX, Liu Y, Xu XX.

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2001 Jan;15(1):49-52. Chinese.

PMID:
12563932
14.

Selection of CD271(+) cells and human AB serum allows a large expansion of mesenchymal stromal cells from human bone marrow.

Poloni A, Maurizi G, Rosini V, Mondini E, Mancini S, Discepoli G, Biasio S, Battaglini G, Felicetti S, Berardinelli E, Serrani F, Leoni P.

Cytotherapy. 2009;11(2):153-62. doi: 10.1080/14653240802582125.

PMID:
19301169
15.

Matrix-associated implantation of predifferentiated mesenchymal stem cells versus articular chondrocytes: in vivo results of cartilage repair after 1 year.

Marquass B, Schulz R, Hepp P, Zscharnack M, Aigner T, Schmidt S, Stein F, Richter R, Osterhoff G, Aust G, Josten C, Bader A.

Am J Sports Med. 2011 Jul;39(7):1401-12. doi: 10.1177/0363546511398646. Epub 2011 Apr 28.

PMID:
21527412
16.

BM cells giving rise to MSC in culture have a heterogeneous CD34 and CD45 phenotype.

Kaiser S, Hackanson B, Follo M, Mehlhorn A, Geiger K, Ihorst G, Kapp U.

Cytotherapy. 2007;9(5):439-50.

PMID:
17786605
17.

In vitro multipotentiality and characterization of human unfractured traumatic hemarthrosis-derived progenitor cells: A potential cell source for tissue repair.

Lee SY, Miwa M, Sakai Y, Kuroda R, Matsumoto T, Iwakura T, Fujioka H, Doita M, Kurosaka M.

J Cell Physiol. 2007 Mar;210(3):561-6.

PMID:
17171634
18.

[Allogenic transplantation of human mesenchymal stem cells for tissue engineering purposes: an in vitro study].

Niemeyer P, Seckinger A, Simank HG, Kasten P, Südkamp N, Krause U.

Orthopade. 2004 Dec;33(12):1346-53. German.

PMID:
15578255
19.

In vivo autologous recellularization of a tissue-engineered heart valve: are bone marrow mesenchymal stem cells the best candidates?

Vincentelli A, Wautot F, Juthier F, Fouquet O, Corseaux D, Marechaux S, Le Tourneau T, Fabre O, Susen S, Van Belle E, Mouquet F, Decoene C, Prat A, Jude B.

J Thorac Cardiovasc Surg. 2007 Aug;134(2):424-32. Epub 2007 Jul 12.

PMID:
17662783
20.

Multipotent mesenchymal stromal cells and immune tolerance.

Noël D, Djouad F, Bouffi C, Mrugala D, Jorgensen C.

Leuk Lymphoma. 2007 Jul;48(7):1283-9. Review.

PMID:
17613755
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk